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Summary 
B10.Q (H-2q) mice congenic for the truncated  T  cell receptor (TCR) V~  a and Va  c haplotypes 
were derived to examine the influence of TCR Va genomic deletions in murine collagen-induced 
arthritis (CIA). Previous studies using gene complementation and segregation analyses suggested 
that  in  SWR  (H-2q)  mice,  possession  of the  Va  n gene  deletion  results  in  CIA  resistance. 
However,  other  studies  have  suggested  alternative  hypotheses.  Thus,  analysis  of TCR  Va 
congenic  mice  allows  for  direct  examination  of  Va  genotypes  in  CIA  control.  After 
immunization  with bovine type II collagen, B10.Q-Va" mice showed no difference in arthritis 
susceptibility, onset, or severity when compared with prototype B10.Q mice. In contrast, B10.Q- 
Va  c mice,  which lack the Va6,  15,  17,  and  19 families in addition  to the Va  a deletion,  were 
highly  resistant  to  CIA.  In  vivo depletion  of Va6 §  T  cells  in  B10.Q-V~  '  mice  significantly 
delayed arthritis onset suggesting that, among those Va genes present in Va  ' but absent in V~  c, 
Va6 § T  cells contribute to arthritogenesis.  Our findings show that, in B10.Q-V~ congenic mice, 
while the Va  n genotype does not prevent CIA, the highly truncated Va  ' genotype renders  B10.Q 
mice resistant to CIA. Thus,  deletions within the Va TCR genome can indeed influence CIA 
and suggests that the TCR repertoire displays only marginal flexibility in response to arthritogenic 
stimuli. 
C 
ollagen-induced  arthritis  (CIA) l  in  mice  is  an  ex- 
perimental animal model bearing similarities to human 
rheumatoid arthritis.  CIA is typically induced by immunizing 
geneticaUy susceptible mice with native type II collagen (CII) 
in CFA (1). Both humoral (2) and cellular (3) immunity against 
CII can be detected in this inflammatory polyarthritis.  Al- 
though anti-CII  antibodies contribute to the arthritogenic 
process (4),  severe and chronic arthritis  stems from activa- 
tion of CII-reactive T  cells (5, 6) responsible for the release 
and/or induction of proinflammatory cytokines such as IFN-3', 
TNF-ot,  and IL-1  (7-10). 
Previous studies established that  susceptibility to CIA is 
associated with genes of the MHC, in particular gene prod- 
ucts residing within the H-2A subregion (1). Mouse strains 
that  bear the H-2q or H-2  r haplotype can consistently de- 
velop CIA,  whereas strains bearing  other haplotypes such 
as H-2  b or H-2 a are  highly  resistant  (1).  However, among 
the H-2q strains,  SWR and AUAsJ fail to develop CIA (11, 
1 Abbreviations used in this paper: CIA, collagen-induced arthritis; CII, 
native type II collagen. 
12). Likewise, RIIIs/J (H-2  r) mice are similarly CIA resis- 
tant (13). Work by Behlke et al. (14) showed that SWR mice 
were among  four mouse strains  that  possess a deletion  of 
~50%  of their Va genome.  A  similar deletion was subse- 
quently detected in the AUAsJ strain (12). These strains have 
been designated as V~ n haplotype and lack the members of 
the V~8 and 5 gene families  as well as the V~9,  11, 12, and 
13 gene segments (14). In addition, Haqqi et al. (15) showed 
that  RIIIs/J animals  also possess a highly  truncated  TCR 
V~  genotype composed of the  genes  deleted  in  V~  n mice 
along with four additional V~ genes (V~6,  15,  17, and 19). 
This unique deletion  has been designated V~  c and encom- 
passes  ~70%  of the V~ genome. 
To  determine  whether  the  TCR  V~  deletion  in  SWR 
contributes to CIA resistance,  gene complementation studies 
were undertaken.  Analysis of F2 progeny from  a cross be- 
tween the SWR strain and B10 mice, which bear the CIA- 
resistant  H-2  b haplotype but possess the wild-type V~  b geno- 
type, revealed that these offspring were CIA susceptible and 
a strong correlation between arthritis  susceptibility, posses- 
sion of the Va  b allele, and homozygosity for the H-2q haplo- 
type was observed (16).  A dominant role for C5 deficiency 
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nated by the observation that offspring of a cross between 
SWR mice and A/Sn animals (Vo  b, C5 deficient) remained 
susceptible to CIA (17). Taken together, these findings sug- 
gested that the V~  ' genotype may confer resistance to CIA 
in SWR  and other H-2q mice. 
Interestingly, subsequent studies examining the role of the 
V~  ~ deletion  in  CIA  resistance  have  been  controversial. 
Spinella et al. (18) and Andersson et al. (19) reported no corre- 
lation between CIA susceptibility and V0 haplotype in ar- 
thritic F2 progeny of a DBA/1  x  SWR cross.  It is unclear 
whether genes provided by the DBA/1 genome, a strain prone 
to the development of spontaneous arthritis (20), contributed 
to these observations. Attempts to modulate arthritis induc- 
tion in DBA/1 mice, by depleting T  cells using V~ TCRs 
encoded within  the  VO  a deletion,  have  led  to  conflicting 
results (21-23).  Finally,  Mori et al.  (24) demonstrated that 
in the expression of a transgenic TCR/5 chain, derived from 
a CII-reactive arthritogenic T cell clone, mice failed to confer 
CIA susceptibility in SWR mice. However, expression of this 
transgene  enhanced  CIA  development  in  (DBA/1  x 
SWR)F1 mice. This observation supports a role for TCR 
V~ genes in arthritogenesis. In addition, the varying effects 
of this  V~  TCR  transgene  on  CIA,  in  the  context  of 
different  genetic  backgrounds,  underscored  the  multiple 
genetic control of this autoimmune disease. 
Given the polygenic nature of CIA in mice, it is clear why 
previous gene complementation and transgenic studies have 
failed to unequivocally determine the influence of TCR V~ 
gene deletions on the induction and development of arthritis. 
To directly address this issue, it is necessary to derive strains 
of CIA susceptible mice congenic for the three known V0 
haplotypes. Such an approach eliminates the contribution of 
background genes in the experimental outcome, a problem 
inherent in gene complementation analysis.  Thus, we have 
developed lines of B10.Q (H-2q) mice congenic for the V~  a 
and Va  c genotype. We report here that, in the B10.Q strain, 
possession of the V~  ~ TCR gene deletion has  no influence 
on the induction or development of CIA. However, B10.Q 
mice congenic for the V~  c genotype were highly resistant to 
CIA. Our studies demonstrate that, in association with cer- 
tain background genes, TCK V~ haplotypes can indeed play 
a major role in CIA development and illustrates the necessity 
of particular TCR V~ genes in the generation of arthrito- 
genic responses against  CII. 
Materials and Methods 
Mice.  All mice used in this study were bred and maintained 
in the Immunogenetics Mouse Colony of the Mayo Clinic. Breeding 
of the TCR Va congenic lines was achieved as detailed in Fig. 1. 
Mice of both sexes were used in this study and were 8-12 wk of 
age at the beginning  of the experiment. 
Induction of CIA.  Native bovine CII, isolated and purified as 
previously described (1), was dissolved overnight at 4~  in 0.01 N 
acetic acid and then emulsified at a 1:1 ratio with CFA (Mycobac- 
teriura tuberculosis strain H37Ra; Difco Laboratories Inc., Detroit, 
MI). Mice were immunized with 100/xl (containing 100/~g bo- 
vine CII) of cold emulsion intradermaUy, at the base of the tail. 
(BIO.Q[V,6b])  X  C57L[V6a]) F~  X  BIO.Q 
Vl3b/V13  b  Vl3b/Vl3a 
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Figure 1.  Diagrammatic illustration of the generation of congenic 
B10.Q-Vaa mice. Segregation  of the V~' allele was evaluated by expres- 
sion of V~8.2 TCR on PBL. The generation of B10.Q-Va  c mice was 
achieved in a similar fashion using (Rill s/J[Vac] ￿  B10.Q)Et  mice in the 
original backcross with B10.Q. 
All mice were monitored three to four times a week for CIA devel- 
opment over a 16-wk period.  Arthritic severity was determined 
as detailed previously (1) using a scoring system for each paw as 
follows: 1, redness or swelling in paw or toes; 2, severe swelling 
and/or joint deformity; 3, joint ankylosis. The arthritic score per 
paw was summed to give a maximal possible score of 12 for each 
individual animal. The mean arthritic score/group was determined 
using arthritic  mice only. 
Flow Cytometric Analysis.  Determination  of normal Vo TCR 
expression in B10.Q B10.Q-Vo  a, and B10.Q-Vo  c mice was achieved 
as follows: briefly, splenic T lymphocytes were purified by incuba- 
tion over a nylon wool column using  standard procedures (25). 
The nonadherent  cells were  washed extensively in  phosphate- 
buffered saline containing 1% bovine serum albumin and 0.1% so- 
dium azide. Approximately 106 cells were then incubated with one 
of the following Va TCR-specific mAbs: B20.6, rat anti-Va2 (26); 
KT4, rat anti-Va4 (27); MR9-8,  mouse anti-Va5.1 (28); MR9-4, 
mouse anti-V~5.1.2 (29); 44-22-1, rat anti-Va6 (30); TIL310, rat 
anti-Va7 (31); F23.1, mouse anti-Va 8.1.2.3 (32); KJ16, rat anti- 
Va8.1.2 (33); F23.2, mouse anti-Va8.2 (34); MR10-2, mouse anti- 
Va9; RR3-15,  rat  anti-Vail  (35); 14-2, rat  anti-Val4 (36); and 
KJ23a, mouse anti-Val7a (37). After a 30-min incubation at 4~ 
the cells were washed then incubated with an FITC-conjugated 
Fab'2 fragment specific  for either mouse IgG, rat IgG, or rat IgM 
(Accurate Chemical & Science Corp.,  Westbury, NY).  After ex- 
tensive washing, all samples received  a 1:1 mixture of mAbs specific 
for mouse CD4 and CD8  (GIBCO BILL, Gaithersburg,  MD) 
directly conjugated with phycoerythrin or RED 613, respectively. 
The cells were then incubated 30 min at 4~  washed, and fixed 
with 1% formalin before analysis. To determine the level of cir- 
culating Va6 T cells after in vivo treatment with the Va6-specific 
mAb 44-22-1, mice were bled via the tail artery and the lympho- 
cyte population was isolated  by centrifugation over a FicoU-Hypaque 
gradient. After washing, the cells were treated as detailed above. 
The level of Va TCR expression on peripheral CD4 + and CD8 + 
lymphocytes  was determined by three-color  fluorescence  flow cytom- 
etry using FACS  |  Vantage flow cytometer (Becton Dickinson & 
Co., Mountain  View, CA). 
Statistical Analysis.  The incidence of arthritis between groups 
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arthritic severity between groups was determined using the non- 
parametric Mann-Whitney  U test. 
Results 
Generation of BIO.Q-V~ Congenic Mice.  The goal of this 
study was to directly address  the role of V~ TCR gene de- 
letions in the induction and perpetuation of CIA. Thus, con- 
genic mice of the B10.Q background were developed which 
possessed  either the truncated Vfl  ￿9 or V~c genotypes. Fig.  1 
illustrates the breeding strategy employed to derive the V~ 
TCR congenic lines.  Briefly, V0b-bearing  B10.Q mice were 
mated with C57L (V~") animals and the F1 progeny were 
backcrossed to B10.Q.  Offspring of the (B10.Q  x  C57L)F1 
x  B10.Q cross were typed for MHC haplotype using stan- 
dard  hemagglutination  techniques,  and  "CO haplotype by 
flow cytometric analysis  of PBL  using  the  V~8.2-specific 
mAb F23.2. Mice that typed as H-2q/q, V~/b were selected 
and backcrossed to the B10.Q strain for 10 generations. After 
the 10th backcross,  V~  "/b offspring were intercrossed and the 
VB  ~/' progeny selected to establish the congenic B10.Q-V~  ~ 
line. Establishment of the B10.Q-V~ c line was achieved using 
a similar strategy in which Vat-bearing RIIIs/J mice were 
initially mated  with  B10.Q mice and  the  Va  b/c offspring 
selected during backcross generations to B10.Q. 
Analysis of Pen'pheral V~ TCR Repertoire in BIO.Q-Vn Con- 
genie Mice.  Given the introduction of truncated Vt~ geno- 
types into B10.Q mice, the expression of V0 TCK on splenic 
T cells in B10.Q, B10.Q-Vo ~, and B10.Q-Vo ~ animals was de- 
termined.  Using  a  panel  of Vo  TCR-specific mAb,  flow 
cytometric analysis revealed that, in general,  both B10.Q-Vo  a 
and B10.Q-Vo  c mice displayed an increase in expression of 
nondeleted Va TCR (Table 1). Interestingly, introduction of 
the functional Vo17a gene in B10.Q-V~  a mice led to a high 
expression of V~17 + T  cells in the CD4 subset.  No differ- 
ence was observed in the CD4/CD8 ratio between the B10.Oo 
B10.Q-Vo ', and B10.Q-V~  c strains (data not shown). In both 
the  B10.Q-Vo"  and  B10.Q-Vo  c  strains,  the  panel  of VO 
TCR-specific mAbs used for analysis accounted for "~38 and 
21%  of the  total  CD4 +  and  CD8 +  T  cell populations, 
respectively.  In  contrast,  82  and  67%  of the  Va-bearing 
CD4 + and CD8 + T  cells could be accounted for in B10.Q 
mice. Therefore, a majority of Vt~ TCR genes that were not 
quantitated by flow cytometry (Vo 1, 3, 10,  15,  16,  18,  19, 
and 20) appear to be used by the congenic B10.Q-Vt# and 
B10.Q-V~  ~ mice to shape their respective peripheral TCR 
repertoires. 
CIA Susceptibility in BIO.Q-V~ Mice.  To determine the 
influence of the V;r  haplotype in H-2q-restricted CIA,  the 
susceptibility of congenic B10.Q-Vo a mice to arthritis induc- 
tion was evaluated. Fig.  2 shows that, after immunization 
with bovine CII, B10.Q-V~"  mice remained susceptible to 
CIA. Analysis of 23 animals demonstrated that the B10.Q- 
V~  ~ strain displayed no noticeable difference in susceptibility, 
disease onset, or arthritic severity when compared with BIO.Q 
mice. Thus, in BIO.Q mice, possession of the VO  a genotype 
does not affect the induction or development of CIA. 
Arthritis Susceptibility in BIO.Q-V~"  Mic~  To test the effect 
Table  1.  Peripheral  Expression of VB T Cell Receptors in BIO.Q, BIO.Q-V~, and BIO.Q-V/s' Mice* 
Percentage of positive T  cells (mean _+ SD) 
B10.Q  B10.Q-V0"  B10.Q-Va  ~ 
Vo  CD4  CD8  CD4  CD8  CD4  CD8 
Va2  2.3 _+ 0.3  0.3  + 0.1  3.9 _+ 2.6  0.9 +  1.0  9.9 + 0.8  3.0 _+ 2.0 
VO4  6.2 _+ 0.5  2.8 + 0.5  8.8 +  1.2  6.1 + 0.3  14.8 _+ 1.8  8.3 _+ 1.3 
V~5.1.2  4.8 _+ 0.5  15.6 _+ 0.2  Deleted  Deleted  Deleted  Deleted 
Va5.1  2.7 + 0.3  6.6 _+ 1.1  Deleted  Deleted  Deleted  Deleted 
V06  2.9 _+ 1.0  5.1 _+ 0.6  5.4 _+ 0.9  5.8 +  1.9  Deleted  Deleted 
V~7  1.6 + 0.1  3.3 _+ 0.3  2.3 + 0.2  4.8 + 0.5  2.5 + 0.7  6.8 _+ 2.1 
V~8.1.2.3  21.8 + 3.7  13.5 _+ 2.7  Deleted  Deleted  Deleted  Deleted 
Va8.1.2  12.8 _+ 1.2  3.5 _+ 1.1  Deleted  Deleted  Deleted  Deleted 
Va8.2  13.4 _+ 0.4  7.6 + 0.4  Deleted  Deleted  Deleted  Deleted 
V~9  1.6 _+ 0.6  3.1 + 0.9  Deleted  Deleted  Deleted  Deleted 
V~11  5.3 + 0.5  3.4 _+ 0.6  Deleted  Deleted  Deleted  Deleted 
Va14  7.0 +_ 3.3  1.9 _+ 2.4  6.3  +  1.5  1.5 + 0.6  8.7  + 1.8  3.0  + 0.5 
Va17  Nonfunctional  Nonfunctional  12.9 + 0.9  2.2 _+ 0.4  Deleted  Deleted 
* Normal B10.Q, B10.Q-VtP, and B10.Q-Vo  c mice were killed and their splenic T lymphocytes  isolated and stained for V3 TCR expression as detailed 
in Materials and Methods. Mean values _+ SD were determined based on three experiments. 
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Figure 2.  Development of CIA in congenic B10.Q-Vo  ~ mice. B10.Q 
(solid  line,  n  =  23) and B10.Q-V~ mice (broken  line,  n  =  23) were im- 
munized with 100 #g bovine CII in CFA on day 0 and monitored regu- 
larly for the &velopment of CIA. No difference in CIA severity was ob- 
served between the two groups. 
of a highly truncated V~ TCK genome on H-2q-restricted 
CIA, the susceptibility of B10.Q-Va  c mice to arthritis induc- 
tion  was  also  determined.  In  contrast  to  the  B10.Q-Va  a 
strain,  B10.Q-V~ r mice were markedly resistant  to CIA (Fig. 
3). After immunization with bovine CII, only 4 of 13 animals 
developed arthritis over the 16-wk observation period, with 
2 of the 4 arthritic mice displaying a transient disease. In ad- 
dition, Fig. 4 illustrates  that, of the B10.Q-V~  ~ mice that de- 
veloped CIA, arthritic  severity was mild compared with B10.Q 
animals.  These findings show that the highly truncated V~  c 
genotype can dramatically  alter arthritis  susceptibility in B10.Q 
mice. 
Modulation  of CIA  Development  in BIO.Q-V~ ~ Mice  Upon 
In  Vivo  Depletion  of Va6 + T  Cells.  The  susceptibility of 
B10.Q-Va  a mice and resistance  of B10.Q-Va  c animals  to CIA 
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Figure 3.  Kesistance of B10.Q-V0  ~ mice to CIA after immunization 
with bovine CII. B10.Q {solid  line,  n  =  10) and B10.Q-V0  ~ mice (broken 
line,  n  =  13) were immunized  with 100 #g bovine CII in CFA and moni- 
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Figure 4.  Progression of arthritis  in B10.Q and B10.Q-Va  r mice. Ar- 
thritic B10.Q (solid  line)  and B10.Q-Va  r (broken  line)  mice from Fig. 3 were 
monitored for the progression  of clinical  arthritis. The mean arthritic severity 
in B10.Q-Vr  mice was significantly lower (p <0.01) vs, B10.Q animals 
throughout the experiment. 
suggested that  Vfl genes present  in  the V~  a genotype but 
absent in VO  c (V~6,  15,  17,  and  19) may play a role in ar- 
thritogenesis. Previous work by Anderson et al. (38) showed 
that the clonal elimination of Mls-1 a reactive T  cells (Vo6, 
7,  8.1,  and 9), by mating  B10.Q mice with CIA resistant 
BALB.D2.Mls-1 ~ congenic animals,  could lead to a decreased 
incidence of CIA in the Ft progeny. Moreover, PCR anal- 
ysis of Vfl mKNA transcripts  from arthritic joints of CII- 
immunized  B10.Q mice revealed  a predominance  of V~8.2 
and Vfl6 TCRs (39).  Together, these three findings strongly 
suggested that in the B10.Q strain,  V~6-bearing T cells may 
play a role in  the induction  and/or  progression  of CIA. 
To determine the contribution  of Vfl6 + T  cells in CIA, 
the effect of depleting  V~6-bearing  T  cells  in vivo on  ar- 
thritis induction in B10.Q-Vo  a mice was examined. As seen 
in Fig.  5,  administration  of the V~6-specific  mAb 44-22-1 
to B10.Q-V~  ~ mice 3  d before immunization  with bovine 
CII significantly delayed the development of CIA when com- 
pared with control animals treated with PBS (mean day of 
onset:  64 d vs. 42 d, p  =  0.019).  Analysis of PBL showed 
a marked reduction of Vo6 + T  cells in both the CD4 and 
CD8 subsets of anti-V~6-treated  mice for up to 28 d with 
detectable levels of Vo6 § T  cells measured by 42 d (Fig.  6). 
Therefore, these data show that the early depletion of Vfl6 + 
T  cells can modulate arthritogenesis in B10.Q-V~  ' mice. In 
addition,  these findings implicate a role for Vfl6-bearing T 
cells in the recognition of arthritogenic epitopes on CII and 
the eventual induction  of CIA. 
Discussion 
It is known that  susceptibility to CIA in mice is depen- 
dent upon possession of the appropriate MHC haplotype (1) 
as well as CII specific arthritogenic T cells (5, 6). The T cell 
dependence of this disease has led to the suggestion that the 
population of T cells specific for CII may use a limited reper- 
toire of TCR V~ and Va genes. Indeed,  a concerted effort 
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Figure 5.  Delay  of CIA development  in B10.Q-Va' mice after in vivo 
depletion of Va6 + T cells. B10.Q-Ve'  mice were given an injection  of 100 
/zg i.v. of the anti-Va6 mAb 44-22-1 (broken line, n =  8) or 100/xl of 
PBS (solid line, n = 8) on day -3. On day 0, both groups  were  immunized 
with 100/~g bovine  CII in CFA. The day of CIA onset was significantly 
delayed in anti-Va6-treated mice compared  with controls (mean day of 
onset _+ SEM: anti-Va6 = 64.3 _+ 10.4, PBS = 42.2 _+ 6.5, p = 0.019). 
to test this hypothesis has been put forth by numerous inves- 
tigators. However, unequivocal demonstration of a restricted 
TCR repertoire in CIA has remained elusive.  Clearly, the 
polygenic nature of CIA,  as well as species  specific differ- 
ences in the arthritogenicity of CII (40), have hampered at- 
tempts at reconciling experimental discrepancies among var- 
ious  laboratories.  Such  discrepancies  are  best  depicted  in 
experiments devoted to examining the role of the Va  a gene 
deletion in CIA (16-19).  Initial studies by Banerjee et al. (16), 
using progeny of a B10  x  SWR cross,  suggested that pos- 
session of the Va  ~ genotype results in CIA resistance. In con- 
trast, studies by Spinella et al. (18) and Andersson et al. (19), 
using DBA/1  x  SWR crosses, found no correlation between 
the Vr  haplotype and CIA resistance.  Therefore, it was the 
goal of this study to develop TCR V~ congenic B10.Q mice 
in an effort to directly examine the role of V~ haplotypes 
on CIA. Our data show that in the B10.Q strain, possession 
of the Vo  a genotype has no influence on CIA susceptibility. 
However, the arthritogenic TCR V~ repertoire displays only 
a limited degree of flexibility since introduction of the se- 
verely truncated Va  c genotype renders B10,Q mice resistant 
to CIA. 
Development of TCR Va congenic mice allows one the 
opportunity to not only examine the influence of such gene 
deletions in autoimmune diseases, but also  a chance to ex- 
plore the effect of V~ haplotypes on TCR repertoire devel- 
opment in a fixed genetic background. In the B10.Q back- 
ground,  both  congenic  Va  ￿9 and  V~  c animals  displayed  a 
generalized increase in the expression of nondeleted Va gene 
families with B10.Q-Va  c mice expressing the most dramatic 
enhancement.  Analysis  of TCR  V~  congenic  B10  mice 
which possessed  either the H-2  b,k  .....  haplotypes yielded 
similar results (Nabozny, G. H., unpublished observations). 
Moreover, the observation that approximately one third of 
the Va + T  cells were accounted for by flow cytometry in 
B10.Q-Va  a and B10.Q-Va  c mice implicates a major contri- 
bution of the Va 1, 3,  10, 15, 16, 18, 19, and 20 TCR genes 
in the peripheral repertoire of these mice. 
Given the current discrepancies surrounding the role of 
the V~  ~ genotype in CIA resistance in SWR (H-2q) mice, 
it was of  great interest to determine the susceptibility of  B10.Q- 
Va  a mice  to  CIA.  After immunization with  bovine CII, 
B10.Q-V~ a mice displayed no difference in arthritis suscep- 
tibility,  onset or severity when compared with prototype 
B10.Q animals (Fig.  2).  This finding clearly shows that in 
B10.Q mice, possession  of the V~  a genotype alone is insuffi- 
cient to cause CIA resistance. 
Previous studies from our laboratory demonstrated that 
offspring of a (C57L[V~  "]  x  SWR)FI  x  C57L cross failed 
to develop CIA  (17),  thereby further implicating  the Va  ~ 
genotype in CIA resistance.  In light of our current findings 
in B10.Q-Va  ~ mice, it is dear that additional genetic factors, 
possibly  in  combination  with  the  Va  ~ haplotype,  render 
some H-2q animals CIA resistant.  It is possible that C57L 
mice share an unidentified genetic lesion with the SWR strain 
that contributed to the previous observations. Alternatively, 
the presence of the heterozygous H-2  b/q haplotype in (C57L 
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Figure 6.  Level  of V~6 + T cells in B10.Q-Va" 
mice after administration of  anti-Va6 mAb. 
B10.Q-V~ mice were injected with 100/zg anti- 
Va6 mAb (open squares) or 100 ~1PBS (solid circle) 
i.v. on day 0. The levels of circulating CD4 + (A) 
and CD8 + (/3) V~6-bearing T cells in PBL was 
determined  by flow  cytometric  analysis as described 
in Materials and Methods. The mean percent + 
SD was calculated  based  on three to six mice/time 
point. 
521  Nabozny  et al. tion of a low frequency of arthritogenic CII epitopes in as- 
sociation with I-Aq due to competition with I-A  b,  a CIA 
nonsusceptible haplotype (1). This decrease,  together with 
the V~  ~ genotype,  may have resulted in  suboptimal  trig- 
gering of arthritogenic T cells. The incidence of CIA in (B10- 
Va  ~ ￿  B10.Q-Va~)Ft mice is currently under analysis to ad- 
dress  this hypothesis. 
Although the B10.Q-Vtr  strain displayed a similar pattern 
of arthritis susceptibility to B10.Q mice, one cannot say a 
priori that the mechanisms underlying the arthritogenic re- 
sponse  is  identical  in  both  strains.  To  date,  two  H-2q- 
restricted T cell epitopes on the CII molecule, residues 181-209 
and 260-270,  have been identified which may play a role in 
CIA (41, 42). It is possible that B10.Q-Va  ~ T  cells respond 
to only one of the two determinants, but, this response may 
still be sufhcient to induce arthritis (Fig. 7). A second possi- 
bility is that introduction of the Va  ~ genotype may lead to 
the recognition of a distinct  determinant within  the im- 
munodominant  peptide,  as  previously  shown  for  H-2  d- 
restricted responses against the  110-121  peptide  of sperm 
whale myoglobin (43-45). Finally, it is also possible that the 
genetic backgrounds in the H-2q-bearing  SWB,,  DBA/1, 
and B10.Q strains generate different self peptides that may 
modulate and/or influence potential CII-reactive T cells. Fur- 
ther studies are required to delineate the nature of CII-specific 
T  cell responses in B10.Q-Va"  mice. 
In  contrast  to  the  V~  ~ haplotype,  introduction  of the 
highly truncated Va  c genotype in B10.Q mice resulted in a 
marked resistance to CIA (Fig. 3). The differential suscepti- 
bility between the B10.Q-V~ ~ and B10.Q-V~ ~ strains pro- 
vided an opportunity to map candidate VO TCR genes in- 
volved in the arthritogenic response.  In vivo depletion of 
Va6 + T  cells in B10.Q-Va' animals led to significant delay 
in arthritis onset compared with control mice (Fig. 5). Thus, 
in the B10.Q background, Va6 + T  cells participate in the 
induction of CIA. This finding is indirectly supported by 
two lines of experimental evidence. First, offspring of a (B10.Q 
￿  BALB.D2.mls')p1  cross, which lack Va6 + T  cells due to 
a Mls-l~-mediated clonal deletion, displayed a reduced inci- 
dence of CIA (38).  Second, Haqqi et al. (39) demonstrated 
a  retention  of Va6  mRNA  transcripts  arthritic joints  of 
B10.Q mice. Molecular analysis of Va6 alleles between V~  ~- 
and Vab-haplotype mice revealed only minor differences (46) 
suggesting that our findings using B10.Q-Va ~ mice are com- 
patible with the aforementioned observations in Va  b strains. 
The demonstration that V~6 + T  cells contribute to CIA 
in B10.Q animals is in contrast to previous studies using an- 
other H-2q strain, DBA/1. Chiochia et al. (21), Horn et al. 
(22), and Goldschmidt et al. (23), reported no effect on CIA 
induction in DBA/1  mice after the in vivo elimination of 
Va6 * T  cells.  However, analysis of CII-reactive T  cell hy- 
bridoma clones from DBA/1 mice immunized with CII re- 
vealed a predominant usage of Val +,  Va8.2 +,  and Va6 + 
TCRs (47).  On balance, our findings, in association with 
the previous studies, illustrate that a multiplicity of factors 
are responsible for shaping the arthritogenic TCR repertoire. 
Although our experimental approach using congenic mice 
precludes identification of such putative factors, our data does 
shed light on understanding the influence of Va TCR geno- 
types in CIA, Yet, one must note that even a small propor- 
V13  b  Mice 
(Full complement of V I~ genes) 
Absent  in  V13  a 
CIA 
V13  a  Mice 
(50% deletion of V~ genes) 
~ 
V13 #2 
CIA  with  little  or  no 
clinical  difference 
V13  c  Mice 
(70% deletion of V~ genes) 
APC 
Absent  in  Vi3  c  Absent  in  V13  c 
Profound  inhibition 
of  CIA  development 
vs.  V15  b  animals 
Figure 7.  Possible mechanism for CIA development in B10.Q-V~ congenic mice. Epitopes nos. 1 and 2 correspond to the H-2q-restricted  T cell 
determinants  181-209 (41) and 260-270 (42) on the CII molecule, respectively. 
522  Collagen-induced  Arthritis in VO TCR Congenic Mice tion of B10.Q-Vr  c mice still retained the ability to develop 
arthritis. Thus, identifying those factors which act in con- 
cert with TCR Va genes requires  thorough investigation. 
Previous  studies suggest that candidate factors may include 
species specific differences  in CII arthritogenicity (40)  and 
TCR V,~ genotypes (48).  Additionally, the identification of 
non-MHC, non-TCR genetic influences  in CIA, as previ- 
ously reported for the nonobese diabetic mouse model of type 
I diabetes  (49-51)  remains to be determined. Clearly, eluci- 
dation of these influences  is needed for a complete under- 
standing of the mechanisms responsible  for arthritogenesis. 
In closing, this study is the first  attempt to directly ad- 
dress the influence of TCR Va genotypes on murine CIA. 
The use of TCR V~ congenic mice not only allows a means 
to test the role of these genotypes in the generation of ar- 
thritis, but also examines the contribution of truncated V~ 
genomes in the formation of the arthritogenic TCR reper- 
toire.  Moreover,  the  development  of TCR  Va  congenic 
strains  on a variety of H-2 haplotypes will enable investi- 
gators to address  similar questions in other models of au- 
toimmune disease. Answers to such issues may lead to a better 
understanding of the mechanisms underlying the develop- 
ment and triggering of autoimmune responses. 
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